Angiopoietin-like protein 8 (betatrophin) inhibits hepatic gluconeogenesis through PI3K/Akt signaling pathway in diabetic mice

• Published in: Metabolism, clinical and experimental clinical and experimental, 2022-01, Vol.126, p.154921-154921, Article 154921
• Main Authors: Zhao, Zhicong, Deng, Xia, Jia, Jue, Zhao, Li, Wang, Chenxi, Cai, Zhensheng, Guo, Chang, Yang, Ling, Wang, Dong, Ma, Suxian, Deng, Jialiang, Li, Haoxiang, Zhou, Libin, Tu, Zhigang, Yuan, Guoyue
• Format: Article
• Language: English
• Subjects: Adenovirus; Angiopoietin-like protein 8; Angiopoietin-Like Protein 8 - genetics; Angiopoietin-Like Protein 8 - metabolism; Animals; Diabetes; Diabetes Mellitus, Experimental - genetics; Diabetes Mellitus, Experimental - metabolism; Diet, High-Fat; Gluconeogenesis - genetics; Hepatic gluconeogenesis; Hepatocytes - metabolism; Insulin Resistance - genetics; Liver - metabolism; Male; Mice; Phosphatidylinositol 3-Kinases - metabolism; Proto-Oncogene Proteins c-akt - metabolism; Signal Transduction - genetics
• ISSN: 0026-0495; 1532-8600
• DOI: 10.1016/j.metabol.2021.154921

Angiopoietin-like protein 8 (ANGPTL8) is a 198 amino-acid long, novel secreted protein that is mainly expressed in the liver and brown adipose tissues. At present, evidence supporting the involvement of ANGPTL8 in the regulation of glucose metabolism is inconclusive, along with its function in the liver. Previous studies mainly focused on the effect of ANGPTL8 on glucose metabolism in non-diabetic mice, and few relevant studies in diabetic mice exist. Therefore, this study aimed to investigate the role of ANGPTL8 on glucose homeostasis and elucidate the underlying mechanisms in diabetic mice. db/db diabetic and high-fat diet/streptozotocin-induced diabetic mice were injected with adenovirus expressing ANGPTL8 through the tail vein. Blood glucose levels were measured and glucose, insulin, and pyruvate tolerance tests were performed. To explore the molecular mechanism by which ANGPTL8 regulates hepatic glucose metabolism and manipulate mouse ANGPTL8 expression levels both in vivo and in vitro based on adenoviral transduction, gain- and loss-of-function strategies were adopted. Adenovirus-mediated overexpression of ANGPTL8 decreased fasting blood glucose levels and improved glucose tolerance and insulin sensitivity in db/db and high-fat diet/streptozotocin-induced diabetic mice. ANGPTL8 knockdown yielded the opposite effects. ANGPTL8 was upregulated in the cAMP/Dex-induced hepatocyte gluconeogenesis model. Moreover, ANGPTL8 overexpression in primary hepatocytes and diabetic mouse livers inhibited the expression of gluconeogenesis-related genes, including PEPCK and G6PC, by activating the AKT signaling pathway and, thereby, reducing glucose production. Therefore, the results demonstrated that ANGPTL8 improved glucose metabolism via inhibition of hepatic gluconeogenesis in diabetic mice. Current findings highlight a critical role of hepatic ANGPTL8 in glucose homeostasis, suggesting that increased ANGPTL8 expression could be an underlying factor for the inhibition of hepatic gluconeogenesis, which could be targeted for the prevention and treatment of type 2 diabetes. •We investigated the effect of ANGPTL8 on glucose homeostasis in diabetic mice.•ANGPTL8 decreases fasting blood glucose levels and improves glucose tolerance.•ANGPTL8 overexpression inhibits gluconeogenesis through AKT signaling.•ANGPTL8 expression could be a factor for inhibiting hepatic gluconeogenesis.•The mechanism may be targeted for prevention and treatment of type 2 diabetes.